Shearman & Sterling advised Boston Scientific Corporation, as issuer, on a €900 million registered offering of 0.625 percent senior notes due 2027 and related cash tender offer for up to $1 billion aggregate principal amount of certain outstanding senior notes. The company used the net proceeds from the Euro offering to fund the waterfall tender offer and pay accrued and unpaid interest, premiums, fees and expenses.

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties.

The Team